−0.6280SEK
−40.21 MSEK
50.78 M
About LIDDS AB
Sector
CEO
Jenni Björnulfson
Headquarters
Uppsala
Website
Employees (FY)
2
Founded
1999
ISIN
SE0001958612
FIGI
BBG006WXTK48
LIDDS AB develops pharmaceutical products for cancer and other diseases with NanoZolid technology. Its pipeline include NZ-Liproca Depot, NZ-DTX, NZ-DOX, NZ-IO, NZ-TLR9 and NZ-STING. The company was founded on November 4, 1999 and is headquartered in Uppsala, Sweden.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of LIDDS is 0.15 SEK — it has decreased by 3.24% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange LIDDS AB stocks are traded under the ticker LIDDS.
Yes, you can track LIDDS AB financials in yearly and quarterly reports right on TradingView.
Like other stocks, LIDDS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade LIDDS AB stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 16, 2024, the company has 2.00 employees. See our rating of the largest employees — is LIDDS AB on this list?